Response
The purpose of the advisory entitled "Wine and Your Health" 1 was to review the current literature and to generate a reasonable message based on the strongest studies that could direct health care providers to methods for improving both the cardiovascular and general health of their patients. Although there are scientific correlates that add to the plausibility of wine and other alcoholic beverages as cardioprotective agents, there are also data that do not show atheroprotective actions. 2 We advocate the use of alternative approaches for several reasons.
First, data for alcohol or wine consumption do not reach the usual standards to recommend this as a primary or secondary prevention approach. Most data are correlative and suffer from a number of confounders (reviewed by Corrao et al 3 ) . In this context, observational and biological plausibility data in the area of cardiovascular disease are not always supported by the results of randomized clinical trials, as has been exemplified by the recent findings in studies using hormone replacement therapy or vitamin E. The use of such incomplete data on alcoholic beverage consumption to make a broad clinical recommendation is especially inappropriate when alternative approaches to the same problem, such as blood pressure control and cholesterol lowering, have been proven to reduce cardiovascular disease in randomized trials. The alcohol data are not as strong.
Second, as noted by Dr Peele, alcohol is the "most commonly consumed psychoactive substance in the United States and the world." Moreover, this substance is addictive in a subgroup of people and is responsible for a large degree of mortality (much more than that found with other cardioprotective medications). If alcohol were a conventional "drug," these side effects would prohibit its use as a cardioprotective agent.
Therefore, we do not believe that physicians and other health care providers should advocate the use of wine or other alcoholic beverages as health-promoting substances but rather should continue to advocate and address the importance of other lifestyle behaviors. This view is separate from any limited use of alcohol as a beverage.
Most importantly, providing the public with a rationale to increase a behavior that is one of the leading causes of disease is not reasonable. Perhaps if we could ensure that all patients limit their alcohol intake to prescribed amounts, alcohol-related illnesses would not occur. If the authors of these letters have a method to do this, it would be a major boon for the health of the nation. Even if this were achieved, however, the evidence to support the benefits of alcohol consumption at a safe level is, at present, still below the standard required for other drugs. If evidence from randomized trials in which alcohol reduced cardiovascular disease without leading to liver, neurological, or psychosocial illness were to become available, we would be happy to include it in a revised advisory in the future.
